PRGO Q3 2024 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q3 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-3.2% YoY

Gross Profit

$404M37.2% margin

Operating Income

$80M7.4% margin

Net Income

-$21M-1.9% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

$15M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$11.2B

Total Liabilities

$6.6B

Stockholders' Equity

$4.6B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.1B	-3.2%
Gross Profit	$404M	$411M	-1.7%
Operating Income	$80M	$62M	+29.5%
Net Income	-$21M	$14M	-247.9%

Revenue Segments

Consumer Self-Care Americas

$671M62%

Consumer Self-Care International

$416M38%

Geographic Segments

UNITED STATES

$657M60%

Europe

$397M36%

Other Geographical Areas

$33M3%

IRELAND

$11M1%